Löhle, Matthias
Wolz, Martin
Beuthien-Baumann, Bettina
Oehme, Liane
van den Hoff, Jörg
Kotzerke, Jörg
Reichmann, Heinz
Storch, Alexander http://orcid.org/0000-0002-1133-9216
Funding for this research was provided by:
Pfizer Pharma GmbH (NA)
Article History
Received: 11 September 2019
Accepted: 11 December 2019
First Online: 20 December 2019
Compliance with ethical standards
:
: M. Löhle has received has received honoraria for presentations from Bayer Healthcare and UCB Pharma. Dr. Wolz reports personal fees from Boehringer Ingelheim, Zambon, Valeant, Desitin, TEVA, UCB Pharma, Abbvie, Licher, and Daiichi Sankyo, outside the submitted work. B. Beuthien-Baumann has received honoraria for presentations/lectures from BRACCO and Roche Pharma AG, Basel, Switzerland. Dr. Oehme reports no disclosures. Dr. van den Hoff reports no disclosures. Dr. Kotzerke reports no disclosures. H. Reichmann was acting on advisory boards and gave lectures and received research grants from Bayer Health Care, Boehringer/Ingelheim, Cephalon, Desitin, GlaxoSmithKline, Merck-Serono, Novartis, Orion, Pfizer, Solvay, TEVA/Lundbeck, UCB Pharma, and Valeant. Dr. Storch has received funding from the Deutsche Forschungsgemeinschaft (DFG) and the Helmholtz Association. He received unrestricted research grants from GKC Melbourne, Pfizer, and TEVA Pharma, honoraria for presentations/lectures/consultancies or advisory boards from AbbVie, Bayer Healthcare, Bial, GKC, Grünenthal, UCB, Zambon, Ca, AbbVie, TEVA, Lundbeck, and UCB Pharma, outside the submitted work. He has served on the editorial boards of Stem Cells and Stem Cells International.